Motley Fool  Nov 12  Comment 
Johnson & Johnson's top-selling prostate cancer treatment is facing a stiff challenger in Medivation's Xtandi, but an acquisition may not be in the cards.
SeekingAlpha  Nov 11  Comment 
Reuters  Nov 10  Comment 
(Corrects paragraph 6 to say Xtandi is marketed by Medivation and Astellas)
TheStreet.com  Nov 5  Comment 
SAN FRANCISCO (TheStreet) -- The prostate cancer drug Xtandi, developed by Medivation's  and sold through a marketing partnership with Astellas, continues post better-than-expected sales numbers. Late last week, Astellas reported...
Motley Fool  Oct 6  Comment 
Medivation stock is up more than 1,000% over the past three years and yet is still considered a cheap stock when using this Wall Street metric. Find out why Wall Street has fallen in love with Medivation, and whether or not the stock can head higher.
TheStreet.com  Sep 24  Comment 
NEW YORK (TheStreet) -- Shares of Medivation Inc. are down today 0.43% to $98.17aafter the company was downgraded to "neutral" from "buy" at Goldman Sachs. Goldman lowered the San Francisco-based biopharmaceutical company's ratings based on a...
SeekingAlpha  Sep 24  Comment 
By ONeil Trader: Medivation (NASDAQ:MDVN) has been among the top performing biotech stocks since bottoming in late April 2014. The company is benefiting from strong sales of its only drug Xtandi, as revenue grew significantly since the drug's...



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki